Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
World
Daniel Keane

‘Fresh hope’ for brain cancer patients as vaccine extends survival in trial

A vaccine is prepared by a nurse (File picture)

(Picture: PA Archive)

A vaccine trialled at a London hospital has been found to significantly prolong life in patients with aggressive brain tumours.

The DCVAX-L, trialled at King’s College Hospital and other centres around the world, can extend survival for patients with recurrent glioblastoma for several months or years.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.